Pancreatic Tumors

Results of Effective Electroporation Therapy in Mice Announced

Published in Cancer Weekly, March 2nd, 1998

Genetronics Biomedical Ltd., San Diego, California, announced that the results of preclinical experiments using Genetronics' proprietary electroporation therapy to treat human pancreatic tumors in mice were published in the December 1997 issue of the journal "Drug Delivery" (vol. 4).

Primary human pancreatic tumors were subcutaneously implanted in nude mice and then treated with a single intratumoral injection of bleomycin followed ten minutes later by electrical pulsing. The objective response at day 28 was 88% - complete response 68% and 20% partial response (more than 80% reduction in tumor volume).

In contrast, tumor volumes of the animals in...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1998-03-02)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry